Interestingly, SLFN11 expression can be driven by gain‐of‐function JAK mutations [38] and activation of the JAK–STAT pathway was linked with hyperresponsiveness to IFN‐γ in an MSI‐H CRC cell line [39]. This evidence concerns the gene IFNG and colorectal carcinoma.